Equities analysts forecast that K2M Group Holdings Inc (NASDAQ:KTWO) will announce earnings of ($0.16) per share for the current quarter, Zacks Investment Research reports. Two analysts have provided estimates for K2M Group’s earnings, with the lowest EPS estimate coming in at ($0.21) and the highest estimate coming in at ($0.10). K2M Group posted earnings of ($0.20) per share during the same quarter last year, which indicates a positive year over year growth rate of 20%. The business is expected to announce its next quarterly earnings report on Wednesday, November 7th.
According to Zacks, analysts expect that K2M Group will report full year earnings of ($0.77) per share for the current financial year, with EPS estimates ranging from ($0.84) to ($0.68). For the next year, analysts anticipate that the company will post earnings of ($0.57) per share, with EPS estimates ranging from ($0.70) to ($0.47). Zacks’ earnings per share calculations are an average based on a survey of research firms that cover K2M Group.
K2M Group (NASDAQ:KTWO) last posted its earnings results on Wednesday, August 1st. The medical device company reported ($0.25) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.19) by ($0.06). K2M Group had a negative net margin of 14.49% and a negative return on equity of 16.27%. The firm had revenue of $73.58 million during the quarter, compared to analyst estimates of $70.85 million. During the same quarter in the previous year, the business posted ($0.21) earnings per share. The business’s quarterly revenue was up 12.0% compared to the same quarter last year.
NASDAQ:KTWO opened at $27.37 on Tuesday. K2M Group has a 1 year low of $16.44 and a 1 year high of $27.50. The company has a current ratio of 3.48, a quick ratio of 2.13 and a debt-to-equity ratio of 0.51. The firm has a market capitalization of $1.19 billion, a P/E ratio of -31.45 and a beta of 1.61.
In other K2M Group news, CFO Gregory S. Cole sold 82,304 shares of the firm’s stock in a transaction on Thursday, August 30th. The shares were sold at an average price of $27.40, for a total value of $2,255,129.60. Following the sale, the chief financial officer now directly owns 147,963 shares in the company, valued at approximately $4,054,186.20. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CFO Gregory S. Cole sold 1,480 shares of the firm’s stock in a transaction on Thursday, August 16th. The stock was sold at an average price of $20.08, for a total transaction of $29,718.40. Following the completion of the sale, the chief financial officer now owns 65,659 shares in the company, valued at $1,318,432.72. The disclosure for this sale can be found here. Insiders sold a total of 84,479 shares of company stock worth $2,298,880 over the last 90 days. Company insiders own 6.00% of the company’s stock.
A number of hedge funds and other institutional investors have recently bought and sold shares of the business. Rhumbline Advisers grew its position in K2M Group by 7.4% in the 2nd quarter. Rhumbline Advisers now owns 39,058 shares of the medical device company’s stock worth $879,000 after purchasing an additional 2,682 shares during the last quarter. Northern Trust Corp grew its position in K2M Group by 0.5% in the 1st quarter. Northern Trust Corp now owns 549,513 shares of the medical device company’s stock worth $10,413,000 after purchasing an additional 2,756 shares during the last quarter. Suntrust Banks Inc. grew its position in K2M Group by 5.1% in the 1st quarter. Suntrust Banks Inc. now owns 64,608 shares of the medical device company’s stock worth $1,223,000 after purchasing an additional 3,126 shares during the last quarter. Sei Investments Co. grew its position in K2M Group by 4.3% in the 2nd quarter. Sei Investments Co. now owns 96,897 shares of the medical device company’s stock worth $2,181,000 after purchasing an additional 4,001 shares during the last quarter. Finally, Westwood Management Corp IL grew its position in K2M Group by 13.5% in the 2nd quarter. Westwood Management Corp IL now owns 42,000 shares of the medical device company’s stock worth $945,000 after purchasing an additional 5,000 shares during the last quarter.
About K2M Group
K2M Group Holdings, Inc, a medical device company, provides spine and minimally invasive solutions in the United States and internationally. The company offers implants, disposables, and instruments primarily to hospitals for use by spine surgeons to treat spinal pathologies, such as deformity, trauma, and tumor.
Read More: Compound Annual Growth Rate (CAGR)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for K2M Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for K2M Group and related companies with MarketBeat.com's FREE daily email newsletter.